药店国别: 产地国家:美国 处方药:是所属类别: 20毫升/瓶 包装规格: 20毫升/瓶 计价单位:瓶生产厂家中文参考译名: 生产厂家英文名:SMITHKLINE BEECHAM 原产地英文商品名:BEXXAR 131 IODINE THERAPEUTIC 20mL/Vial 原产地英文药品名:TOSITUMOMAB IODINE-131 中文参考商品译名:百克沙 131 IODINE THERAPEUTIC 20毫升/瓶 ...
BiodrugsNews (2003) Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab. BioDrugs 17:290–295...
BEXXAR治疗(Tositumomab治疗I-131)注射液 [葛兰素史克公司] 注射,静脉滴注 最初美国批准:2003年 最近的重大变化 禁忌症去除 警告和注意事项,胚胎,胎儿毒性 适应症 BEXXAR(Tositumomab治疗和碘我131 Tositumomab治疗)是1抗CD20-定向放射治疗抗体治疗的患者CD20阳性,复发或难治性,低档,滤泡表示,或改变非霍奇金淋巴瘤,其...
Iodine-131 tositumomab [B1, Bexxar™, iodine-131 anti-B1 antibody] is a murine antibody conjugated to iodine 131 that recognises and binds to the B1 (CD20) antigen which is found specifically on B lymphocytes. Iodine-131 tositumomab has a dual mechanism of action. It is capable of initiati...
部份中文托西莫单抗处方资料(仅供参考) 药品英文名:Tositumomab 药品别名:Bexxar 药物剂型:托西莫单抗注射剂:225mg;35mg,蛋白浓度为14mg/ml。131I-托西莫单抗注射剂:20ml,含131I 0.61mCi,蛋白浓度0.1mg/ml。 药理作用:托西莫单抗是一种在正常及恶性B淋巴细胞表面发现的鼠抗CD20抗原IgG2aλ单克隆抗体,能与CD20抗原...
PURPOSE: To evaluate the efficacy and safety of tositumomab and iodine I 131 tositumomab (Bexxar; Corixa Corp, Seattle, WA, and GlaxoSmithKline, Philadelphia, PA) in patients with chemotherapy-refractory low-grade or transformed low-grade non-Hodgkin's lymphoma (NHL) and to compare its efficacy ...
英文别名:3:PN: WO2008003319 PAGE: 45 claimed sequence; Bexxar; Iodine I131 tositumomab; Tositumab CAS号:192391-48-3英文供应商查看 中文商机查看 英文商机查看 客户服务 市场:0571-88228153 服务:0571-88228209 内容:0571-88228217 zlh@netsun.com 技术:0571-88228212 contadm@netsun.com 兄弟...
MATERIALS AND METHODS: Herein we review clinical experience with tositumomab and iodine I 131 tositumomab (Bexxar; Corixa Corporation; South San Francisco, ... JM Vose - 《Oncologist》 被引量: 113发表: 2004年 The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I ...
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan PURPOSE: This multicenter phase II study evaluated the efficacy, dosimetry methodology, and safety of iodine-131 tositumomab in patients with chemotherapy-... JD Pineda - 《Journal of Clinical Endocrin...
131I-tositumomab therapy as initial treatment for follicular lymphoma. BACKGROUND: Advanced-stage follicular B-cell lymphoma is considered incurable. Anti-CD20 radioimmunotherapy is effective in patients who have had a relapse... MS Kaminski,M Tuck,J Estes,... - 《N Engl J Med》 被引量: 1426...